1. Home
  2. low coverage

Low-coverage whole-genome sequencing of cerebrospinal-fluid-derived cell-free DNA in brain tumor patients - ScienceDirect

$ 4.50

4.5 (134) In stock

Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas

PDF) The emerging role of cell-free DNA as a molecular marker for cancer management

Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma - ScienceDirect

Serial assessment of measurable residual disease in medulloblastoma liquid biopsies - ScienceDirect

Sequencing of cerebrospinal fluid cell-free DNA facilitated early differential diagnosis of intramedullary spinal cord tumors

Circulating tumor DNA profiling for childhood brain tumors: Technical challenges and evidence for utility - Laboratory Investigation

Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma - ScienceDirect

PDF) Low-coverage whole-genome sequencing of cerebrospinal-fluid-derived cell-free DNA in brain tumor patients

Cancers, Free Full-Text

Cancers, Free Full-Text

Detection of genes mutations in cerebrospinal fluid circulating tumor DNA from neoplastic meningitis patients using next generation sequencing, BMC Cancer

Frontiers Cerebrospinal Fluid Cell-Free DNA-Based Detection of High Level of Genomic Instability Is Associated With Poor Prognosis in NSCLC Patients With Leptomeningeal Metastases